Prescription drug insurance in Quebec: freezing of the maximum premium and the deductible

QUEBEC — There will be no increase within a year of the maximum amount of the annual premium for Quebec’s public drug insurance plan (RPAM), which therefore remains at $710 until June 30, 2023.

The decision was endorsed by the Council of Ministers following a recommendation by the board of directors of the Régie de l’assurance maladie du Québec (RAMQ).

The Minister of Health and Social Services, Christian Dubé, explains this freeze by the savings produced by the agreements with the manufacturers who wish to have new products included in the Lists of medications of the general prescription drug insurance plan. The favorable pricing conditions and discounts imposed by these agreements thus mitigate the cost associated with covering new drugs.

Minister Dubé specifies that the switch to biosimilar products, which are much less expensive than the reference biological products, has made it possible to create sufficient leeway to allow the insurance premium to be frozen.

In addition to the freezing of the maximum amount, other contribution parameters are recalled, in particular the amount of the deductible, set at $22.25, and the proportion of coinsurance, set at 35%, as well as the monthly contribution of certain people people aged 65 and over.

Leave a Comment